Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index.
<h4>Background</h4>The neuropeptide substance P is a potential biomarker and therapeutic target in cancer. The main objectives of this study were to investigate the expression level of substance P in different breast cancer molecular subtypes and identify its association with clinicopath...
Guardado en:
Autores principales: | Maha S Al-Keilani, Rana I Elstaty, Mohammad A Alqudah, Asem M Alkhateeb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5f58eec8b854c3aab7edc7e87a4ed04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Ceren Boyaci, et al.
Publicado: (2021) -
KI67 AND P53 PROTEINS IN ODONTOGENIC KERATOCYST
por: S Seifi, et al.
Publicado: (2008) -
Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells
por: Rikke H. Dahlrot, et al.
Publicado: (2021) -
An Advanced Deep Learning Approach for Ki-67 Stained Hotspot Detection and Proliferation Rate Scoring for Prognostic Evaluation of Breast Cancer
por: Monjoy Saha, et al.
Publicado: (2017) -
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer
por: Sun JZ, et al.
Publicado: (2014)